CORRELATION OF C–REACTIVE PROTEIN LEVELS AND PLATELET REACTIVITY TO OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PCI: RESULTS OF THE ARMYDA–CRP (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY–C REACTIVE PROTEIN) PROSPECTIVE STUDY